Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Feb 2017 07:00

RNS Number : 3784W
Dairy Crest Group PLC
09 February 2017
 

 

9 February 2017

 

Dairy Crest Group plc ("Dairy Crest")

 

Interim Management Statement

 

Dairy Crest is today issuing its Interim Management Statement for the nine months ended 31 December 2016.

 

Outlook

 

The outlook for the full year remains in line with our expectations.

 

Branded performance

 

Our key brands have continued to perform well. Clover, Frylight and Country Life have all grown volumes in the first nine months of the year and have taken significant share in their respective markets. As predicted, Cathedral City performance improved in the third quarter.

 

Overall, in the first nine months of the year the combined volumes of Cathedral City, Country Life, Clover and Frylight are in line with the same period last year.

 

Innovation and brand building continues to be at the heart of what we do. Clover and Frylight have both seen new packaging launches during the quarter and Frylight has been supported by a new TV advertising campaign over the last six weeks. In January 2017, Clover won the spreads category "Product of the Year 2017" award in the world's largest consumer survey award for product innovation. This is a testimony to the work we undertook to remove artificial ingredients from Clover. Furthermore, in October 2016 Frylight won the Institute of Grocery and Distribution Health and Wellness award. We will continue to invest in innovation and marketing across our key brands through 2017.

 

Functional Ingredients

 

Production of demineralised whey powder and galacto-oligosaccharide ("GOS"), both ingredients for the growing global infant formula market, continues to develop well at our factory in Davidstow. There have been significant improvements in the percentage level of demineralised whey hitting the important infant formula grade. We remain confident that this will continue to rise and that we will hit our target of over 80% by 31 March 2017.

 

On 21 December 2016, Dairy Crest announced that it had entered into a research partnership with Danisco Animal Nutrition, part of DuPont, to further explore the potential uses of GOS in poultry and swine. If successful, this work would help to broaden the potential market for GOS beyond infant formula.

 

Balance sheet

 

We have seen further milk cost inflation since the half year and have now announced increases in the price paid to farmers of 8.28 pence per litre since June 2016. This represents an increase of 38%. Furthermore, market prices for cream have remained high after more than doubling in the first half of the year. The cream price determines the input costs for our butter business. These movements inevitably result in a short-term working capital outflow and, as a result, we now expect year end net debt to be somewhat higher than 31 March 2016.

 

New auditor appointment

 

The Board has approved the appointment of Deloitte as external auditor for the year commencing 1 April 2017. This appointment will be subject to shareholder approval at the 2017 Annual General Meeting. The Group's current auditor, Ernst & Young, is retiring by rotation and will carry out the audit for the year ending 31 March 2017. The Board would like to thank Ernst & Young for their contribution to the business over many years.

 

 

 

Mark Allen, Chief Executive of Dairy Crest, commented:

 

"The outlook for the full year remains in line with our expectations.

 

The business has continued to make progress during the quarter. Our brands have performed well supported by successful innovation and brand investment. I'm particularly pleased to see the improvement in Cathedral City's performance.

 

At the new Davidstow functional ingredients facility we are seeing significant improvement in the percentage level of demineralised whey meeting infant formula grade. This is important in maximising future opportunities in this market.

 

The announcement of the partnership with Danisco Animal Nutrition marks a further significant step in the development of GOS beyond infant formula. This has exciting potential opportunities for the future."

 

 

Dairy Crest will issue its Preliminary Results for the year ending 31 March 2017 on 18 May 2017.

 

 

 

For further information, please contact:

Dairy Crest

Alistair Smith

01372 472236

Dairy Crest

Tom Atherton

01372 472264

Brunswick

Mike Smith

0207 404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQVLFBDLFBBBX
Date   Source Headline
8th Aug 201411:58 amRNSBlocklisting Interim Review
1st Aug 20149:44 amRNSTotal Voting Rights
15th Jul 20145:25 pmRNSAGM Statement
15th Jul 20147:00 amRNSAGM and Interim Management Statement
11th Jul 201410:10 amRNSDirector/PDMR Shareholding
3rd Jul 20147:00 amRNSGlobal partnership with Fonterra
30th Jun 201411:55 amRNSTotal Voting Rights
16th Jun 20143:46 pmRNS2014 Annual Report and Accounts and Notice of AGM
28th May 201410:06 amRNSHolding(s) in Company
22nd May 20147:00 amRNSFinal results for year ended 31 March 2014
1st May 20142:08 pmRNSTotal Voting Rights
8th Apr 201411:01 amRNSHolding(s) in Company
31st Mar 20142:43 pmRNSTotal Voting Rights
7th Mar 20146:12 pmRNSBoard Announcement
28th Feb 20143:30 pmRNSTotal Voting Rights
27th Feb 201412:23 pmRNSBlocklisting Interim Review
18th Feb 201411:07 amRNSHolding(s) in Company
31st Jan 20142:13 pmRNSTotal Voting Rights
31st Jan 20147:00 amRNSIMS and Sale of Nine Elms Depot
10th Jan 201411:26 amRNSDirector/PDMR Shareholding
2nd Jan 201410:03 amRNSTotal Voting Rights
13th Dec 201312:50 pmRNSNon-executive Director Notification
12th Dec 20138:46 amRNSInterim Dividend - Amendment to Record Date
2nd Dec 20139:49 amRNSTotal Voting Rights
12th Nov 20132:14 pmRNSHolding(s) in Company
7th Nov 20137:00 amRNSInterim Results Announcement
4th Nov 20138:52 amRNSHolding(s) in Company
31st Oct 201311:57 amRNSTotal Voting Rights
3rd Oct 20133:45 pmRNSDealings by Directors
30th Sep 201311:41 amRNSTotal Voting Rights
23rd Sep 20137:00 amRNSTrading Update
30th Aug 201311:27 amRNSBlocklisting Interim Review
30th Aug 201311:16 amRNSTotal Voting Rights
27th Aug 20137:00 amRNSDealings by Directors
16th Aug 201311:21 amRNSReplacement - Director/PDMR Shareholding
15th Aug 20133:55 pmRNSDirector/PDMR Shareholding
31st Jul 20139:36 amRNSTotal Voting Rights
17th Jul 201311:12 amRNSReplacement - Result of AGM
17th Jul 20138:59 amRNSResult of AGM
16th Jul 20137:00 amRNSAGM and Interim Management Statement
10th Jul 201311:42 amRNSHolding(s) in Company
3rd Jul 20135:56 pmRNSEmployee Benefit Trust Dealings
3rd Jul 20132:27 pmRNSAnnual Report & Notice of AGM
3rd Jul 201311:36 amRNSHolding(s) in Company
1st Jul 20131:18 pmRNSTotal Voting Rights
28th Jun 20132:38 pmRNSDirector/PDMR Shareholding
28th Jun 20132:34 pmRNSDirector/PDMR Shareholding
28th Jun 201312:15 pmRNSHolding(s) in Company
18th Jun 20134:51 pmRNSHolding(s) in Company
3rd Jun 20133:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.